# Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

> **NCT00835159** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 30 (actual)

## Conditions studied

- Delirium
- Postoperative Cognitive Dysfunction

## Interventions

- **DRUG:** Rivastigmine Patch
- **OTHER:** Placebo Patch

## Key facts

- **NCT ID:** NCT00835159
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00835159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00835159, "Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00835159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*